Rider L G, Shamim E, Okada S, Pandey J P, Targoff I N, O'Hanlon T P, Kim H A, Lim Y S, Han H, Song Y W, Miller F W
Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA.
Arthritis Rheum. 1999 Jun;42(6):1285-90. doi: 10.1002/1529-0131(199906)42:6<1285::AID-ANR28>3.0.CO;2-1.
To better understand genetic contributions to autoimmunity, immunogenetic markers were studied in two racially discrete and geographically isolated populations of patients with idiopathic inflammatory myopathy (IIM).
Clinical characteristics, as well as clinical and autoantibody subsets, were defined in 151 American white patients and 50 Korean patients with IIM. HLA-DRB1 and DQA1 genotyping was performed on patients and racially matched controls by standard molecular techniques. Gm allotypes and phenotypes were determined by the hemagglutination-inhibition method.
HLA-DRB10301, the linked allele DQA10501, and DRB1 alleles sharing the first hypervariable region motif 9EYSTS13 were major genetic risk factors for the development of myositis in whites (corrected P [Pcorr] < 0.0004, odds ratio [OR] 11.2, 4.5, and 3.1, respectively, for each factor versus controls). Although both the white and Korean patients had a similar distribution of clinical characteristics, autoantibody profiles, and clinical groups, no HLA-DRB1 nor DQA1 allele or motif was found to be a risk factor for IIM in the Korean patients. However, DRB1*14 was a protective factor in Korean patients without myositis-specific autoantibodies (Pcorr = 0.004, OR 0.046). In addition, although no Gm phenotype or allotype was identified as a risk factor in whites, Gm 21 was a protective factor for the development of IIM in Koreans (Pcorr = 0.024, OR 0.3).
Although myositis patients in the US and Korea share similar clinical and serologic features, the immune response genes predisposing to and protecting from myositis in each of these ethnic groups differ at two chromosomal loci. These data suggest that multiple genetic loci should be studied to identify risk and protective factors for some autoimmune diseases in various ethnic populations.
为了更好地理解自身免疫的遗传因素,我们在两个种族不同且地理上隔离的特发性炎性肌病(IIM)患者群体中研究了免疫遗传标记。
确定了151名美国白人患者和50名韩国IIM患者的临床特征以及临床和自身抗体亚组。通过标准分子技术对患者及种族匹配的对照进行HLA - DRB1和DQA1基因分型。采用血凝抑制法测定Gm同种异型和表型。
HLA - DRB10301、与之连锁的等位基因DQA10501以及共享第一个高变区基序9EYSTS13的DRB1等位基因是白人发生肌炎的主要遗传危险因素(校正P值[Pcorr]<0.0004,每个因素与对照相比的比值比[OR]分别为11.2、4.5和3.1)。虽然白人和韩国患者在临床特征、自身抗体谱和临床分组上有相似的分布,但未发现HLA - DRB1或DQA1等位基因或基序是韩国患者IIM的危险因素。然而,DRB1*14是没有肌炎特异性自身抗体的韩国患者的保护因素(Pcorr = 0.004,OR 0.046)。此外,虽然在白人中未发现Gm表型或同种异型是危险因素,但Gm 21是韩国人发生IIM的保护因素(Pcorr = 0.024,OR 0.3)。
虽然美国和韩国的肌炎患者具有相似的临床和血清学特征,但在这两个种族群体中,导致和预防肌炎的免疫反应基因在两个染色体位点上存在差异。这些数据表明,应研究多个基因位点以确定不同种族人群中某些自身免疫性疾病的危险因素和保护因素。